Index of reports
> Cases with Dyspnoea (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Perforomist (Formoterol Inhalation) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Perforomist side effects in 84 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27
Patient: 84 year old male, weighing 60.3 kg (132.7 pounds)
Reactions: Dyspnoea, Chronic Obstructive Pulmonary Disease
Drug(s) suspected as cause:
Budesonide
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-06-04
End date: 2011-06-07
Perforomist
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-06-04
Other drugs received by patient: Claritin / 00917501 /; Stool Softener; Flomax; Zolpidem; Naproxen (Aleve); Prednisone TAB; Hydrochlorothiazide; Multi-Vitamin; Singulair; Omega 3 Fatty Acid; CO-Q10-Chlorella; Beano; Ciprofloxacin HCL; Ultram; Lisinopril; Finasteride
Possible Perforomist side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: female
Reactions: Dyspnoea
Drug(s) suspected as cause:
Ipratropium Bromide and Albuterol Sulfate
Indication: Chronic Obstructive Pulmonary Disease
Perforomist
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-01-01
Possible Perforomist side effects in 88 year old female
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: 88 year old female, weighing 58.5 kg (128.7 pounds)
Reactions: Dyspnoea
Drug(s) suspected as cause:
Perforomist
Other drugs received by patient: Cardiac Therapy; Other Respiratory System Products
Possible Perforomist side effects in 74 year old male
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: 74 year old male, weighing 76.7 kg (168.7 pounds)
Reactions: Dyspnoea, Insomnia
Drug(s) suspected as cause:
Perforomist
Other drugs received by patient: Bumex; Aldactone; Prednisone TAB
Possible Perforomist side effects in 64 year old male
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: 64 year old male, weighing 90.7 kg (199.6 pounds)
Reactions: Dyspnoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Perforomist
Perforomist
Start date: 2011-01-01
Other drugs received by patient: Pravastatin; Lisinopril; Mucinex; Ipratropium Bromide; Combivent
Possible Perforomist side effects in 66 year old female
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: 66 year old female
Reactions: Dyspnoea, Insomnia, Heart Rate Irregular
Drug(s) suspected as cause:
Perforomist
Other drugs received by patient: Prilosec; Lopressor; Singulair; Symbicort; Xopenex; Relafen; Prednisone TAB
Possible Perforomist side effects in 69 year old male
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: 69 year old male, weighing 111.1 kg (244.5 pounds)
Reactions: Dyspnoea, Asthenia
Drug(s) suspected as cause:
Perforomist
Other drugs received by patient: Metformin HCL; Simvastatin; Finasteride; Albuterol; Hydrochlorothiazide; Glipizide; Flunisolide; Lisinopril
Possible Perforomist side effects in 72 year old male
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: 72 year old male, weighing 124.7 kg (274.4 pounds)
Reactions: Dyspnoea
Drug(s) suspected as cause:
Perforomist
Indication: Asthma
Start date: 2011-10-10
End date: 2011-10-31
Perforomist
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-10-10
End date: 2011-10-31
Perforomist
Indication: Bronchitis Chronic
Start date: 2011-10-10
End date: 2011-10-31
Other drugs received by patient: Budesonide; Ipratropium Bromide; Albuterol
Possible Perforomist side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-25
Patient: female
Reactions: Dyspnoea
Drug(s) suspected as cause:
Ipratropium Bromide and Albuterol Sulfate
Indication: Chronic Obstructive Pulmonary Disease
Perforomist
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-01-01
|